Cholesterol Metabolite 27-Hydroxycholesterol Enhances the Secretion of Cancer Promoting Extracellular Vesicles by a Mitochondrial ROS-Induced Impairment of Lysosomal Function

Overview

Journal bioRxiv

Date 2024 May 15

PMID 38746134

Authors

Anasuya Das Gupta

Jaena Park

Janet E Sorrells

Hannah Kim

Natalia Krawczynska

Hashni Epa Vidana Gamage

Adam T Nelczyk

Stephen A Boppart

Marni D Boppart

Erik R Nelson

Affiliations

Soon will be listed here.

Abstract

Extracellular vesicles (EVs) serve as crucial mediators of cell-to-cell communication in normal physiology as well as in diseased states, and have been largely studied in regard to their role in cancer progression. However, the mechanisms by which their biogenesis and secretion are regulated by metabolic or endocrine factors remain unknown. Here, we delineate a mechanism by which EV secretion is regulated by a cholesterol metabolite, 27-Hydroxycholesterol (27HC), where treatment of myeloid immune cells (RAW 264.7 and J774A.1) with 27HC impairs lysosomal homeostasis, leading to shunting of multivesicular bodies (MVBs) away from lysosomal degradation, towards secretion as EVs. This impairment of lysosomal function is caused by mitochondrial dysfunction and subsequent increase in reactive oxygen species (ROS). Interestingly, cotreatment with a mitochondria-targeted antioxidant rescued the lysosomal impairment and attenuated the 27HC-mediated increase in EV secretion. Overall, our findings establish how a cholesterol metabolite regulates EV secretion and paves the way for the development of strategies to regulate cancer progression by controlling EV secretion.

References

Bonora M, Giorgi C, Pinton P . Molecular mechanisms and consequences of mitochondrial permeability transition. Nat Rev Mol Cell Biol. 2021; 23(4):266-285. DOI: 10.1038/s41580-021-00433-y. View

Muralidharan-Chari V, Clancy J, Plou C, Romao M, Chavrier P, Raposo G . ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles. Curr Biol. 2009; 19(22):1875-85. PMC: 3150487. DOI: 10.1016/j.cub.2009.09.059. View

Welsh J, Goberdhan D, ODriscoll L, Buzas E, Blenkiron C, Bussolati B . Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J Extracell Vesicles. 2024; 13(2):e12404. PMC: 10850029. DOI: 10.1002/jev2.12404. View

Norgard M, Lund P, Kalisi N, Andresen T, Larsen J, Vogel S . Mitochondrial reactive oxygen species modify extracellular vesicles secretion rate. FASEB Bioadv. 2023; 5(9):355-366. PMC: 10478507. DOI: 10.1096/fba.2023-00053. View

Kelso G, Porteous C, Coulter C, Hughes G, Porteous W, Ledgerwood E . Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J Biol Chem. 2000; 276(7):4588-96. DOI: 10.1074/jbc.M009093200. View

Nelson E, DuSell C, Wang X, Howe M, Evans G, Michalek R . The oxysterol, 27-hydroxycholesterol, links cholesterol metabolism to bone homeostasis through its actions on the estrogen and liver X receptors. Endocrinology. 2011; 152(12):4691-705. PMC: 3230052. DOI: 10.1210/en.2011-1298. View

Latifkar A, Ling L, Hingorani A, Johansen E, Clement A, Zhang X . Loss of Sirtuin 1 Alters the Secretome of Breast Cancer Cells by Impairing Lysosomal Integrity. Dev Cell. 2019; 49(3):393-408.e7. PMC: 6519475. DOI: 10.1016/j.devcel.2019.03.011. View

Thery C, Zitvogel L, Amigorena S . Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002; 2(8):569-79. DOI: 10.1038/nri855. View

Hu Q, Ren J, Li G, Wu J, Wu X, Wang G . The mitochondrially targeted antioxidant MitoQ protects the intestinal barrier by ameliorating mitochondrial DNA damage via the Nrf2/ARE signaling pathway. Cell Death Dis. 2018; 9(3):403. PMC: 5851994. DOI: 10.1038/s41419-018-0436-x. View

10.

Baek A, Yu Y, He S, Wardell S, Chang C, Kwon S . The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells. Nat Commun. 2017; 8(1):864. PMC: 5636879. DOI: 10.1038/s41467-017-00910-z. View

11.

Lam J, Herant M, Dembo M, Heinrich V . Baseline mechanical characterization of J774 macrophages. Biophys J. 2008; 96(1):248-54. PMC: 2710052. DOI: 10.1529/biophysj.108.139154. View

12.

Forgac M . Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology. Nat Rev Mol Cell Biol. 2007; 8(11):917-29. DOI: 10.1038/nrm2272. View

13.

Meehan B, Rak J, Di Vizio D . Oncosomes - large and small: what are they, where they came from?. J Extracell Vesicles. 2016; 5:33109. PMC: 5040817. DOI: 10.3402/jev.v5.33109. View

14.

Settembre C, Perera R . Lysosomes as coordinators of cellular catabolism, metabolic signalling and organ physiology. Nat Rev Mol Cell Biol. 2023; 25(3):223-245. DOI: 10.1038/s41580-023-00676-x. View

15.

Amaral O, Martins M, Oliveira A, Duarte A, Mondragao-Rodrigues I, Macedo M . The Biology of Lysosomes: From Order to Disorder. Biomedicines. 2023; 11(1). PMC: 9856021. DOI: 10.3390/biomedicines11010213. View

16.

Wang T, Gilkes D, Takano N, Xiang L, Luo W, Bishop C . Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis. Proc Natl Acad Sci U S A. 2014; 111(31):E3234-42. PMC: 4128139. DOI: 10.1073/pnas.1410041111. View

17.

Zhou J, Li X, Wu X, Zhang T, Zhu Q, Wang X . Exosomes Released from Tumor-Associated Macrophages Transfer miRNAs That Induce a Treg/Th17 Cell Imbalance in Epithelial Ovarian Cancer. Cancer Immunol Res. 2018; 6(12):1578-1592. DOI: 10.1158/2326-6066.CIR-17-0479. View

18.

Yim W, Mizushima N . Lysosome biology in autophagy. Cell Discov. 2020; 6:6. PMC: 7010707. DOI: 10.1038/s41421-020-0141-7. View

19.

Clancy J, Sedgwick A, Rosse C, Muralidharan-Chari V, Raposo G, Method M . Regulated delivery of molecular cargo to invasive tumour-derived microvesicles. Nat Commun. 2015; 6:6919. PMC: 4497525. DOI: 10.1038/ncomms7919. View

20.

Baek A, Nelson E . The Contribution of Cholesterol and Its Metabolites to the Pathophysiology of Breast Cancer. Horm Cancer. 2016; 7(4):219-28. PMC: 4930376. DOI: 10.1007/s12672-016-0262-5. View